Compare AIHS & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIHS | BFRG |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | China | United States |
| Employees | N/A | 17 |
| Industry | Finance: Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 6.9M |
| IPO Year | 2017 | N/A |
| Metric | AIHS | BFRG |
|---|---|---|
| Price | $1.75 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.0K | ★ 127.6K |
| Earning Date | 02-13-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,389,072.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.25 | $0.43 |
| 52 Week High | $8.26 | $2.20 |
| Indicator | AIHS | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 72.72 | 42.19 |
| Support Level | $1.84 | $0.43 |
| Resistance Level | $3.07 | $0.69 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 67.55 | 14.77 |
Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.